Learn how oncologists are personalizing breast cancer treatment, including whether or not chemotherapy is used, based on the 21 gene recurrence score assay test.

Breast cancer patients are consulting with their primary care physicians on cancer treatment. See how oncologists and PCPs can provide better collaborative care.

National initiative seeks to improve pancreatic cancer clinical trials and pancreatic cancer treatment. Learn more about clinical trials for pancreatic cancer.

Understanding who has the highest risk of rare cancers, including squamous cell esophageal cancer, suggests a potential for targeted screening recommendations.

Learn about a small implanted device capable of detecting and treating metastatic breast cancer earlier and how this technology could improve survival rates.

Despite having stage 4 prostate cancer, 74 year old Woods Brown remains active by fishing and planting. Learn more about Woods and living with prostate cancer.

A metabolic cross-talk pathway between cancer and noncancer cells in pancreatic tumors delivers an alternative nutrient to the cancer cells, facilitating tumor growth.

Researchers explore why more women are having voluntary mastectomies and share insight into the decision making process of patients who elect a double mastectomy.

PARP inhibitors can stop cancer by preventing cancer cells from repairing themselves. See what forms of cancer PARP inhibitors can treat and their side effects.

University of Michigan researchers find that breast cancer patients who are active on social media may be more satisfied with treatment decisions. Here's why.

University of Michigan researchers found that despite rapid growth in post-treatment imaging of thyroid cancer, survival rates have not improved. Find out why.

Researchers found inherited genetic mutations were more common in men with metastatic prostate cancer. Here are two important implications of their findings.

Read the findings of a new study suggesting that acupressure offers a low-cost way for breast cancer patients to manage cancer related fatigue and sleep loss.

After being diagnosed with stage IV prostate cancer, John Loussia climbed Mount Kilimanjaro in support of U-M's Blue Boxer Fund. Learn more about John's journey.

Learn how RhoC gene contributes to the growth of aggressive cancer cells and find out how future cancer treatments may exploit this molecular vulnerability.